| |
|
|
|
|
|
|
|||
|
Blood, 1 December 2008, Vol. 112, No. 12, pp. 4512-4522. Prepublished online as a Blood First Edition Paper on September 19, 2008; DOI 10.1182/blood-2008-05-157560.
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Endoglin expression in blood and endothelium is differentially regulated by modular assembly of the Ets/Gata hemangioblast code1 Department of Haematology, Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom; 2 Lowy Cancer Research Centre and the Prince of Wales Clinical School, University of New South Wales, Sydney, Australia; 3 The Wellcome Trust Sanger Institute, Cambridge, United Kingdom; 4 Institute of Biomedical Research, The Medical School, University of Birmingham, Birmingham, United Kingdom; 5 Cranfield Health, Cranfield University, Cranfield, United Kingdom; and 6 Paterson Institute for Cancer Research, Christie Hospital, Manchester, United Kingdom
Endoglin is an accessory receptor for TGF-β signaling and is required for normal hemangioblast, early hematopoietic, and vascular development. We have previously shown that an upstream enhancer, Eng –8, together with the promoter region, mediates robust endothelial expression yet is inactive in blood. To identify hematopoietic regulatory elements, we used array-based methods to determine chromatin accessibility across the entire locus. Subsequent transgenic analysis of candidate elements showed that an endothelial enhancer at Eng +9 when combined with an element at Eng +7 functions as a strong hemato-endothelial enhancer. Chromatin immunoprecipitation (ChIP)–chip analysis demonstrated specific binding of Ets factors to the promoter as well as to the –8, +7+9 enhancers in both blood and endothelial cells. By contrast Pu.1, an Ets factor specific to the blood lineage, and Gata2 binding was only detected in blood. Gata2 was bound only at +7 and GATA motifs were required for hematopoietic activity. This modular assembly of regulators gives blood and endothelial cells the regulatory freedom to independently fine-tune gene expression and emphasizes the role of regulatory divergence in driving functional divergence.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2008 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||